MediPoint: Breast Cancer Imaging - Global Analysis and Market Forecasts

Summary

Breast cancer is the most common form of cancer in women in both the developed and developing world, but is a rare disease in men. The global incidence of breast cancer is increasing due to an increased lifespan and increasing adoption of western lifestyle risk factors. Early diagnosis of breast cancer is the foundation for increasing survival rates and diagnostic imaging is the most widely used technique to achieve early detection, making diagnostic imaging a cornerstone of breast cancer control.


Diagnostic imaging is used for the early detection of breast cancer in asymptomatic patients in population-based screening programs in most developed countries, or for opportunistic screening in developing nations. Regardless of these differences, imaging has proved to be an indispensable tool in fighting breast cancer and has been proven to reduce mortality. This report provides an analysis of the mammography market (in relation to dedicated breast cancer screening and diagnosis), in the US, the 5EU (France, Germany, Italy, Spain, and UK), Brazil, and the APAC regions, including Japan, China, and India, and identifies the unmet needs in the market. This report also discusses physician attitudes towards current breast cancer screening and diagnostic techniques, and the future of breast cancer imaging modalities in the face of rapid technological advancements.

Highlights

Key Questions Answered

- Breast cancer incidence is expected to increase during the forecast period. (Q). What is the cost of imaging methods? (Q). How will changing demographics and lifestyles affect the incidence of breast cancer and the consequent effects on screening and diagnosis using imaging techniques?
- Tomosynthesis is becoming more popular, as companies promote their products and radiologists demand technology that improves cancer detection. (Q). What is the current perception and adoption of this technique and other nascent techniques in the major markets? (Q). Will tomosynthesis become the ‘gold-standard’ in the forecast period?
- There are a few significant unmet needs. (Q). What are these unmet needs? (Q). How can device manufacturers differentiate themselves from the competition? (Q). What is the Scope for more innovation and what are radiologists looking for in their products?
- The global breast cancer imaging market is a mature industry with complex dynamics. The dynamics of this industry vary greatly from one market to another. (Q). Which countries expect to see the most adoption and what are the hurdles?

Reasons to buy

- “What Physicians Think” quotes provide a unique insight into how healthcare professionals are reacting to events within the industry, and what their responses could mean for industry strategists. In this report you will understand the perceptions of leading breast radiologists from around the world. This information is essential for all strategic decision makers in every organization allowing them to act on high quality information.

Table Of Contents

Table of Contents

1 Table of Contents 6
1.1 List of Tables 15
1.2 List of Figures 20
2 Introduction 24
2.1 Catalyst 25
3 Disease Overview 26
3.1 Anatomy and Physiology of the Breast 26
3.2 Pathophysiology of Breast Cancer 27
3.3 Detection of Breast Cancer 27
3.4 Types of Breast Cancer 28
3.5 Clinical Presentation 30
3.6 Clinical Outcomes 31
3.6.1 Assessment Procedure 31
3.6.2 Screening Guidelines 34
3.7 Epidemiology of Breast Cancer 37
3.8 Economic Impact of Breast Cancer Imaging 40
4 Imaging Techniques 41
4.1 Mammography 41
4.1.1 Overview 41
4.1.2 Types of Mammography 43
4.2 Non-Mammographic Techniques 48
4.2.1 Breast Ultrasound Imaging 48
4.2.2 Breast Magnetic Resonance Imaging 49
4.3 Comparison of Mammography, Ultrasound, and MRI 50
4.4 Alternative Breast Imaging Techniques 51
4.4.1 Nuclear Imaging Techniques 52
4.4.2 Computed Tomography 53
4.4.3 Optical Breast Imaging 54
4.4.4 Electric Impedance-Based Techniques 54
4.4.5 Thermography 55
4.4.6 Elastography 55
4.4.7 Ductogram 55
5 Competitive Assessment 56
5.1 Overview 56
5.2 Film Screen Mammography 57
5.2.1 Performa (GE Healthcare) 57
5.2.2 Alpha RT/Alpha ST (GE Healthcare) 60
5.2.3 MAMMOMAT 1000 (Siemens Healthcare) 63
5.2.4 MAMMOMAT 3000 Nova (Siemens Healthcare) 65
5.2.5 M-IV/M-IV Platinum (Hologic) 67
5.2.6 MammoDiagnost (Philips Healthcare) 69
5.2.7 Planmed Nuance Classic (Planmed) 71
5.2.8 Planmed Sophie Classic (Planmed) 73
5.2.9 Analog Giotto Image (Internazionale Medico Scientifica) 74
5.2.10 HAWK-2M (Hologic) 76
5.2.11 MGU-1000A (Toshiba Medical Systems) 78
5.3 CR Mammography 79
5.3.1 Fuji Computed Radiography Mammography Suite (FCRMS) (Fujifilm Medical Systems) 79
5.3.2 KODAK DirectView (Carestream Health) 82
5.3.3 Xpress CR System (Konica Minolta) 83
5.3.4 REGIUS PureView (Konica Minolta) 85
5.3.5 Agfa CR Mammography Systems (DX-M, CR 30-Xm, and CR 85-X) (Agfa Healthcare) 86
5.4 Full-Field Digital Mammography 88
5.4.1 Selenia Dimensions (Hologic) 88
5.4.2 Selenia (Hologic) 91
5.4.3 Selenia S (Hologic) 93
5.4.4 Selenia Performance (Hologic) 94
5.4.5 Senographe DS (GE Healthcare) 96
5.4.6 Senographe Essential (GE Healthcare) 97
5.4.7 Senographe Care (GE Healthcare) 100
5.4.8 SenoBright CESM (GE Healthcare) 101
5.4.9 MAMMOMAT Inspiration (Siemens Healthcare) 103
5.4.10 Aspire HD (US)/Amulet (Outside the US) (Fujifilm) 105
5.4.11 MammoDiagnost DR (Philips Healthcare) 108
5.4.12 MicroDose (Philips Healthcare) 110
5.4.13 Giotto Image 3D/3DL (Internazionale Medico Scientifica) 112
5.4.14 Planmed Nuance/Nuance Excel (Planmed) 114
5.4.15 Fairy DR (Allengers Medical Systems) 116
5.4.16 Serenity 117
5.5 3D Mammography 118
5.5.1 Selenia Dimensions 3D System (Hologic) 118
5.5.2 True 3D Breast Tomosynthesis (Siemens Healthcare) 120
5.5.3 Giotto Tomo (Internazionale Medico Scientifica) 122
5.5.4 FUJIFILM 3Dimensional Mammography (Fujifilm) 124
5.6 Breast Ultrasound Imaging 126
5.6.1 somo.v Automated Breast Ultrasound (ABUS) (GE Healthcare) 126
5.6.2 SonoCine AWBUS (SonoCine) 128
5.6.3 ACUSON S2000 ABVS (Siemens Healthcare) 129
5.6.4 Terason t3200 Ultrasound System Breast Series (Terason Ultrasound) 131
5.7 Breast MRI 132
5.7.1 Aurora 1.5T Dedicated Breast MRI System (Aurora Imaging Technology) 132
5.8 Other Breast Imaging Techniques 134
5.8.1 PEM Flex Solo II (Naviscan) 134
5.8.2 Computerized Tomography Laser Mammography (CTLM) Model 1020 (Imaging Diagnostic Systems) 136
5.8.3 Dilon 6800/Dilon 6800 Acella (Dilon Diagnostics) 138
5.8.4 LumaGEM (Gamma Medica) 140
5.8.5 Discovery NM 750b (GE Healthcare) 142
6 Unmet Needs 145
6.1 Lower Radiation Dose 145
6.2 Increase Patient Comfort 146
6.3 Reduce False-Positives and False-Negatives 148
6.4 Loss of Sensitivity of Mammography in Dense Breasts 150
6.5 Unreliable Mammograms in Surgically-Operated Breasts and Breasts with Implants 152
6.6 Commitment to Training 153
7 Pipeline Products 155
7.1 Breast Cancer Imaging Pipeline Products Overview 155
7.2 GE Breast Tomosynthesis 156
7.2.1 Overview 156
7.2.2 SWOT Analysis 157
7.3 MAMMOMAT Inspiration PRIME Edition 158
7.3.1 Overview 158
7.3.2 SWOT Analysis 158
7.4 MicroDose SI 159
7.4.1 Overview 159
7.4.2 SWOT Analysis 159
7.5 Selenia Dimensions 2D Contrast-Enhanced Digital Mammography (CEDM) 160
7.5.1 Overview 160
7.5.2 SWOT Analysis 160
7.6 SenoCase 160
7.6.1 Overview 160
7.6.2 SWOT Analysis 161
7.7 Electrical Mammogram 162
7.7.1 Overview 162
7.7.2 SWOT Analysis 162
8 Industry Overview 163
8.1 Purchasing Cycle 163
8.1.1 Product Life Cycle 163
8.1.2 Cost Effectiveness in Screening Settings 165
8.1.3 Cost-Effectiveness in Diagnostic Settings 165
8.2 Market Access 166
8.2.1 Purchasing Decisions 166
8.2.2 Regulatory Process 166
8.3 Quality Assurance 169
8.3.1 US 169
8.3.2 EU 169
8.3.3 Brazil 170
8.3.4 Japan 170
8.3.5 China and India 170
8.4 Adoption of New Technologies 171
8.4.1 Influence of Clinical Trials Results 171
8.4.2 Reimbursement 172
8.4.3 Economic Resources 172
8.4.4 Low Breast Cancer Incidence and Absence of a National Screening Program 172
8.4.5 Competitive Advantage 173
8.5 Current Reimbursement Trends 174
8.5.1 US 174
8.5.2 Europe 175
8.5.3 France 176
8.5.4 Germany 176
8.5.5 Italy 176
8.5.6 Spain 176
8.5.7 UK 177
8.5.8 30TJapan 177
8.5.9 Brazil 177
8.5.10 30TChina 178
8.5.11 30TIndia 178
8.6 Trends in Detector Technology for Digital Mammography 179
8.7 Evolving Scatter-Removal Mechanisms 183
8.8 Overdiagnosis 185
8.9 Malpractice Litigations 186
8.10 Mergers and Acquisitions/Key Partnerships 187
8.10.1 GE Healthcare Acquires U-Systems 187
8.10.2 Koninklijke Philips Electronics Acquires MicroDose Mammography from Sectra 187
8.10.3 Hologic Acquires Beijing Healthcome Technology 187
8.10.4 Hologic Acquires Sentinelle Medica 188
8.10.5 Koninklijke Philips Electronics Acquires Shanghai Apex Electronics Technology 188
8.10.6 Fujifilm Medical Systems acquired FUJIFILM-RU 188
8.10.7 Other Key Events 189
9 Current and Future Players 190
9.1 Overview 190
9.2 Trends in Corporate Strategy 191
9.3 Company Profiles 192
9.3.1 GE Healthcare 192
9.3.2 Hologic 194
9.3.3 Siemens 196
9.3.4 Koninklijke Philips Electronics 197
9.3.5 Fujifilm Medical Systems 199
9.3.6 Internazionale Medico Scientifica (IMS) 200
9.3.7 Planmed 201
9.3.8 Konica Minolta Medical Imaging 202
9.3.9 Agfa Healthcare 203
9.3.10 Carestream Health 204
9.3.11 SonoCine 205
9.3.12 Aurora Imaging Technology 206
9.3.13 Imaging Diagnostic Systems 207
9.3.14 Naviscan 208
9.3.15 Dilon Diagnostics 209
9.3.16 Gamma Medica 209
9.3.17 Allengers Medical Systems 210
10 Market Drivers and Opportunities 211
10.1 Market Drivers 211
10.1.1 Increase in the Incidence of Breast Cancer 211
10.1.2 Increased Awareness of the Benefits of Screening 211
10.1.3 Increased Breast Cancer Incidence Due to an Aging Population 212
10.1.4 FDA Reclassification of Mammography Equipment 212
10.1.5 New Technologies to Drive Market Growth 212
10.1.6 Changes in Age Inclusion Criteria in Breast Cancer Screening Programs 214
10.1.7 Adoption of Digital Mammography Units Worldwide 214
10.2 Opportunities 217
10.2.1 Emerging Economies Promise Future Growth 217
10.2.2 Invest in Emerging Technologies 218
10.2.3 Product Improvement 219
10.3 Market Barriers 219
10.3.1 Shortage of Dedicated Mammography Professionals 219
10.3.2 Reduced Hospital Budgets 220
10.3.3 Refurbished Equipment Sales 221
10.3.4 Reimbursement 221
10.3.5 Substitutes 222
11 Country Outlooks and Forecasts 223
11.1 Major Markets Overview 223
11.2 United States 226
11.2.1 United States Market Analysis 226
11.3 France 230
11.3.1 France Market Analysis 230
11.4 Germany 231
11.4.1 Germany Market Analysis 231
11.5 Italy 232
11.5.1 Italy Market Analysis 232
11.6 Spain 233
11.6.1 Spain Market Analysis 233
11.7 United Kingdom 234
11.7.1 United Kingdom Market Analysis 234
11.8 Japan 235
11.8.1 Japan Market Analysis 235
11.9 Brazil 237
11.9.1 Brazil Market Analysis 237
11.10 China 238
11.10.1 China Market Analysis 238
11.11 India 239
11.11.1 India Market Analysis 239
12 Appendix 241
12.1 Bibliography 241
12.2 Abbreviations 271
12.3 Report Methodology 276
12.3.1 Overview 276
12.3.2 Coverage 276
12.3.3 Secondary Research 276
12.3.4 Forecast Methodology 277
12.4 Physicians and Specialists Included in this Study 278
12.5 Primary Research 279
12.6 Physician Survey 279
12.7 About the Authors 280
12.7.1 Analysts 280
12.7.2 Global Head of Healthcare 281
12.8 Definitions 282
12.9 About MediPoint 282
12.10 About GlobalData 282
12.11 Contact Us 283
12.12 Disclaimer 283

1.1 List of Tables
Table 1: Breast Cancer Types, Including Diagnostic Procedures 29
Table 2: ACR Breast Imaging Reporting and Database System (BI-RADS) 31
Table 3: Selected Breast Cancer Incidence Rates, 2002 38
Table 4: Comparison of Mammography, Ultrasound, and MRI for Breast Imaging 50
Table 5: Performa Product Profile 58
Table 6: Performa SWOT Analysis 59
Table 7: Alpha RT/Alpha ST Product Profile 61
Table 8: Alpha RT/Alpha ST SWOT Analysis 62
Table 9: MAMMOMAT 1000 Product Profile 63
Table 10: MAMMOMAT 1000 SWOT Analysis 64
Table 11: MAMMOMAT 3000 Nova Product Profile 66
Table 12: MAMMOMAT 3000 Nova SWOT Analysis 66
Table 13: M-IV/M-IV Platinum Product Profile 68
Table 14: M-IV/M-IV Platinum SWOT Analysis 68
Table 15: MammoDiagnost Product Profile 70
Table 16: MammoDiagnost SWOT Analysis 70
Table 17: Planmed Nuance Classic Product Profile 72
Table 18: Planmed Nuance Classic SWOT Analysis 72
Table 19: Planmed Sophie Classic Product Profile 73
Table 20: Planmed Sophie Classic SWOT Analysis 74
Table 21: Analog Giotto Image Product Profile 75
Table 22: Analog Giotto Image SWOT Analysis 75
Table 23: HAWK-2M Product Profile 77
Table 24: HAWK-2M SWOT Analysis 77
Table 25: MGU-1000A Product Profile 78
Table 26: MGU-1000A SWOT Analysis 79
Table 27: Fuji Computed Radiography Mammography Suite (FCRMS) Product Profile 81
Table 28: Fuji Computed Radiography Mammography Suite (FCRMS) SWOT Analysis 81
Table 29: KODAK DirectView CR System Product Profile 82
Table 30: KODAK DirectView CR System SWOT Analysis 83
Table 31: Xpress CR System Product Profile 84
Table 32: Xpress CR System SWOT Analysis 84
Table 33: REGIUS PureView Product Profile 85
Table 34: REGIUS PureView SWOT Analysis 86
Table 35: Agfa CR Mammography Systems (DX-M, CR 30-Xm, and CR 85-X) Product Profile 87
Table 36: Agfa CR Mammography Systems (DX-M, CR 30-Xm, and CR 85-X) SWOT Analysis 87
Table 37: FFDM SWOT Analysis 88
Table 38: Selenia Dimensions Product Profile 89
Table 39: Selenia Dimensions SWOT Analysis 90
Table 40: Selenia Product Profile 92
Table 41: Selenia SWOT Analysis 92
Table 42: Selenia S Product Profile 93
Table 43: Selenia S SWOT Analysis 94
Table 44: Selenia Performance Product Profile 95
Table 45: Selenia Performance SWOT Analysis 95
Table 46: Senographe DS Product Profile 96
Table 47: Senographe DS SWOT Analysis 97
Table 48: Senographe Essential/Senographe Essential E Product Profile 98
Table 49: Senographe Essential SWOT Analysis 99
Table 50: Senographe Care Product Profile 100
Table 51: Senographe Care SWOT Analysis 101
Table 52: SenoBright CESM Product Profile 102
Table 53: SenoBright CESM SWOT Analysis 103
Table 54: MAMMOMAT Inspiration Product Profile 104
Table 55: MAMMOMAT Inspiration SWOT Analysis 105
Table 56: Aspire HD/Amulet Product Profile 106
Table 57: Aspire HD/Amulet SWOT Analysis 107
Table 58: MammoDiagnost DR Product Profile 108
Table 59: MammoDiagnost DR SWOT Analysis 109
Table 60: MicroDose Product Profile 111
Table 61: MicroDose SWOT Analysis 111
Table 62: Giotto Image 3D/3DL Product Profile 113
Table 63: Giotto Image 3D/3DL SWOT Analysis 113
Table 64: Planmed Nuance/Nuance Excel Product Profile 115
Table 65: Planmed Nuance/Nuance Excel SWOT Analysis 115
Table 66: Fairy DR Product Profile 116
Table 67: Fairy DR SWOT Analysis 117
Table 68: Serenity Product Profile 118
Table 69: Serenity SWOT Analysis 118
Table 70: Selenia Dimensions 3D System Product Profile 119
Table 71: Selenia Dimensions SWOT Analysis 120
Table 72: True 3D Breast Tomosynthesis Product Profile 121
Table 73: True 3D Breast Tomosynthesis SWOT Analysis 122
Table 74: Giotto Tomo Product Profile 123
Table 75: Giotto Tomo SWOT Analysis 124
Table 76: FUJIFILM 3Dimensional Mammography Product Profile 125
Table 77: FUJIFILM 3Dimensional Mammography SWOT Analysis 125
Table 78: somo.v ABUS Product Profile 127
Table 79: somo.v ABUS SWOT Analysis 127
Table 80: SonoCine AWBUS Product Profile 128
Table 81: SonoCine AWBUS SWOT Analysis 129
Table 82: ACUSON S2000 ABVS Product Profile 130
Table 83: Acuson S2000 ABVS SWOT Analysis 131
Table 84: Terason t3200 Ultrasound System Breast Series Product Profile 132
Table 85: Terason t3200 Ultrasound System Breast Series SWOT Analysis 132
Table 86: Aurora 1.5T Dedicated Breast MRI System Product Profile 133
Table 87: Aurora 1.5T Dedicated Breast SWOT Analysis 134
Table 88: PEM Flex Solo II Product Profile 135
Table 89: PEM Flex Solo II SWOT Analysis 136
Table 90: Computerized Tomography Laser Mammography (CTLM) Model 1020 Product Profile 137
Table 91: Computerized Tomography Laser Mammography (CTLM) Model 1020 SWOT Analysis 138
Table 92: Dilon 6800/Dilon 6800 Acella Product Profile 140
Table 93: Dilon 6800/Dilon 6800 Acella SWOT Analysis 140
Table 94: LumaGEM Product Profile 141
Table 95: LumaGEM SWOT Analysis 142
Table 96: Discovery NM 750b Product Profile 143
Table 97: Discovery NM 750b SWOT Analysis 144
Table 98: Breast Cancer Imaging Pipeline Products 155
Table 99: GE Breast Tomosynthesis SWOT Analysis 157
Table 100: MAMMOMAT Inspiration PRIME Edition SWOT Analysis 158
Table 101: Philips MicroDose SI SWOT Analysis 159
Table 102: Selenia Dimensions 2D Contrast Imaging SWOT Analysis 160
Table 103: SenoCase SWOT Analysis 161
Table 104: Electrical Mammogram SWOT Analysis 162
Table 105: Other Key Events in the Breast Cancer Imaging Market 189
Table 106: GE Healthcare SWOT Analysis, 2013 194
Table 107: Hologic SWOT Analysis, 2013 196
Table 108: Siemens SWOT Analysis, 2013 197
Table 109: Koninklijke Philips Electronics SWOT Analysis, 2013 198
Table 110: Fujifilm Medical Systems, SWOT Analysis, 2013 199
Table 111: Internazionale Medico Scientifica SWOT Analysis, 2013 200
Table 112: Planmed, SWOT Analysis, 2013 201
Table 113: Konica Minolta Medical Imaging, SWOT Analysis, 2013 202
Table 114: Agfa Healthcare, SWOT Analysis, 2013 203
Table 115: Carestream Health, SWOT Analysis, 2013 204
Table 116: SonoCine, SWOT Analysis, 2013 205
Table 117: Aurora Imaging Technology, SWOT Analysis, 2013 206
Table 118: Imaging Diagnostic Systems, SWOT Analysis, 2013 208
Table 119: Naviscan, SWOT Analysis, 2013 208
Table 120: Dilon Diagnostics, SWOT Analysis, 2013 209
Table 121: Gamma Medica, SWOT Analysis, 2013 210
Table 122: Allengers Medical Systems, SWOT Analysis, 2013 210
Table 123: Major Events Affecting the Global Breast Cancer Imaging Market 223
Table 124: Sales Forecasts for Breast Cancer Imaging in the 10 Major Markets, 2009-2018 223
Table 125: Global Forecast for Numbers of Breast Cancer Imaging Systems (Installed Base), 2009-2018 224
Table 126: Sales Forecasts for Breast Cancer Imaging in the US, 2009-2018 226
Table 127: Number of Installations of New Breast Imaging Systems in the US, 2011 and 2018 228
Table 128: Sales Forecasts for Breast Cancer Imaging in France, 2009-2018 230
Table 129: Sales Forecasts for Breast Cancer Imaging in Germany, 2009-2018 231
Table 130: Sales Forecasts for Breast Cancer Imaging in Italy, 2009-2018 232
Table 131: Sales Forecasts for Breast Cancer Imaging in Spain, 2009-2018 233
Table 132: Sales Forecasts for Breast Cancer Imaging in the UK, 2009-2018 234
Table 133: Sales Forecasts for Breast Cancer Imaging in Japan, 2009-2018 235
Table 134: Sales Forecasts for Breast Cancer Imaging in Brazil, 2009-2018 237
Table 135: Sales Forecasts for Breast Cancer Imaging in China, 2009-2018 238
Table 136: Sales Forecasts for Breast Cancer Imaging in India, 2009-2018 239
Table 137: Physicians Surveyed, By Country 279

1.2 List of Figures
Figure 1: Anatomy of the Breast 26
Figure 2: Breast Cancer Screening, Diagnostic Evaluation, and Follow-Up 32
Figure 3: Percentage Use of Ultrasound Imaging and MRI for Breast Cancer Screening and Follow-Up, 2009-2016 33
Figure 4: Breast Cancer Risk Factors 37
Figure 5: Average Worldwide Breast Cancer Incidence, CAGR, 2012-2018 39
Figure 6: Global Trends in Breast Cancer Incidence, 2012-2018 39
Figure 7: Comparison Between Digital (FFDM) and Analog (FSM) Mammography 44
Figure 8: Use of Alternative Breast Imaging Modalities, 2009-2016 51
Figure 9: Performa 58
Figure 10: Alpha RT 60
Figure 11: Alpha ST 61
Figure 12: MAMMOMAT 1000 63
Figure 13: MAMMOMAT 3000 Nova 65
Figure 14: M-IV/M-IV Platinum 67
Figure 15: MammoDiagnost 69
Figure 16: Planmed Nuance Classic 71
Figure 17: Planmed Sophie Classic 73
Figure 18: Analog Giotto Image 74
Figure 19: HAWK-2M 76
Figure 20: MGU-1000A 78
Figure 21: Aspire CRm 80
Figure 22: KODAK DirectView CR System 82
Figure 23: Xpress CR System 83
Figure 24: REGIUS PureView Type M 85
Figure 25: DX-M Digitizer 86
Figure 26: Selenia Dimensions 89
Figure 27: Selenia 91
Figure 28: Selenia S 93
Figure 29: Selenia Performance 94
Figure 30: Senographe DS 96
Figure 31: Senographe Essential 98
Figure 32: Senographe Care 100
Figure 33: SenoBright CESM* 102
Figure 34: MAMMOMAT Inspiration 104
Figure 35: Aspire HD 106
Figure 36: MammoDiagnost DR 108
Figure 37: MicroDose 110
Figure 38: Giotto Image 3D/3DL 112
Figure 39: Planmed Nuance/Nuance Excel 114
Figure 40: Fairy DR 116
Figure 41: Serenity 117
Figure 42: Selenia Dimensions 2D System 119
Figure 43: True 3D Breast Tomosynthesis* 121
Figure 44: Giotto Tomo 123
Figure 45: Fujifilm 3D Mammography Viewer 125
Figure 46: somo.v ABUS 126
Figure 47: SonoCine AWBUS 128
Figure 48: ACUSON S2000 ABVS 130
Figure 49: Terason t3200 Ultrasound System Breast Series 131
Figure 50: Aurora 1.5T Dedicated Breast MRI System 133
Figure 51: PEM Flex Solo II 135
Figure 52: CTLM Model 1020 137
Figure 53: Dilon 6800 Acella 139
Figure 54: Dilon 6800 139
Figure 55: LumaGEM 141
Figure 56: Discovery NM 750b 143
Figure 57: Percentage of False-Positive, False-Negative and Accurate Breast Cancer Diagnoses from 2011-2012 149
Figure 58: Senographe Essential 156
Figure 59: SenoCase 161
Figure 60: Product Life Cycle 164
Figure 61: Breast Screening Programs in the EU 175
Figure 62: Detector Evolution 179
Figure 63: Comparison Between a Typical Direct Conversion Detector and a Direct Optical Switching Detector 181
Figure 64: Photon-Counting Detector Technology 183
Figure 65: Linear and High Transmission Cellular Grids 184
Figure 66: Increase in FFDM Systems in the US, 2004-2013 215
Figure 67: Trends in the Use of Mammographic Techniques, 2009-2016 216
Figure 68: Sales Forecasts for Breast Cancer Imaging in the 10 Major Markets, 2009-2018 224
Figure 69: Global Breast Cancer Imaging Market Revenue, by Region, 2011 and 2018 225
Figure 70: Sales Forecasts for Breast Cancer Imaging in the US, 2009-2018 226
Figure 71: Total Number of Breast Imaging Facilities and Total Number of Facilities with FFDM Units in the US, 2008-2013 227
Figure 72: Percentage of Installations of New Breast Imaging Systems in the US in 2011 and 2018 229
Figure 73: Sales Forecasts for Breast Cancer Imaging in France, 2009-2018 230
Figure 74: Sales Forecasts for Breast Cancer Imaging in Germany, 2009-2018 231
Figure 75: Sales Forecasts for Breast Cancer Imaging in Italy, 2009-2018 232
Figure 76: Sales Forecasts for Breast Cancer Imaging in Spain, 2009-2018 233
Figure 77: Sales Forecasts for Breast Cancer Imaging in the UK, 2009-2018 234
Figure 78: Sales Forecasts for Breast Cancer Imaging in Japan, 2009-2018 236
Figure 79: Sales Forecasts for Breast Cancer Imaging in Brazil, 2009-2018 237
Figure 80: Sales Forecasts for Breast Cancer Imaging in China, 2009-2018 238
Figure 81: Sales Forecasts for Breast Cancer Imaging in India, 2009-2018 23



Companies Mentioned

GE Healthcare
Hologic
Siemens
Koninklijke Philips Electronics
Fujifilm Medical Systems
Internazionale Medico Scientifica (IMS)
Planmed
Konica Minolta Medical Imaging
Agfa Healthcare
Carestream Health
SonoCine
Aurora Imaging Technology
Imaging Diagnostic Systems
Naviscan
Dilon Diagnostics
Gamma Medica
Allengers Medical Systems

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers

Future Horizons and Growth Strategies in the Global Diagnostic Imaging Market 2014: Strategic Assessments of Leading Suppliers

Future Horizons and Growth Strategies in the Global Diagnostic Imaging Market 2014: Strategic Assessments of Leading Suppliers

  • $ 14 500
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $14,500.  Individual company assessments $2,450.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...

Future Horizons and Growth Strategies in the Global Ultrasound Market 2014: Strategic Assessments of Leading Suppliers

Future Horizons and Growth Strategies in the Global Ultrasound Market 2014: Strategic Assessments of Leading Suppliers

  • $ 12 500
  • Industry report
  • August 2014
  • by Venture Planning Group

Complete report $12,500.  Individual company assessments $1,850.  The report is available by company, section, market segment, and can be custom-tailored to your specific information needs and budget. ...

Future Horizons and Growth Strategies in the Global MRI Market 2014: Strategic Assessments of Leading Suppliers

Future Horizons and Growth Strategies in the Global MRI Market 2014: Strategic Assessments of Leading Suppliers

  • $ 7 400
  • Industry report
  • August 2014
  • by Venture Planning Group

This report provides diagnostic imaging industry executives with strategically significant competitor information, analysis and insight crucial to the development and implementation of effective business, ...

Global Bone Densitometers Market

September 2014 $ 4 950

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.